EUVIMEDEUVIMED entdecken
Open Access

Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke

Ernst Mayerhofer iD, Christoph Strecker iD, Heiko Becker iD, Marios K Georgakis iD, Md Mesbah Uddin iD, Michael M Hoffmann iD, Niroshan Nadarajah, Manja Meggendorfer, Torsten Haferlach, Jonathan Rosand iD, Pradeep Natarajan iD, Christopher D Anderson iD und 2 weitere

Stroke · 2023

DOI: 10.1161/strokeaha.122.041416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke, 2023. Verfasst von Ernst Mayerhofer und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurophysiology (E.M., C.S., A.H.), Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Germ…. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Stroke. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association-American Stroke Association, NHLBI NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Undetermined stroke etiology hampers optimal secondary prevention in a large proportion of young patients. We explored whether genetic screening for clonal hematopoiesis of indetermined potential (CHIP), a novel risk factor for stroke, could identify patients with myeloid precursor lesions or covert myeloid neoplasm requiring specific treatment.

Methods

We performed targeted sequencing on 56 genes recurrently mutated in hematologic neoplasms in a prospective cohort of patients with acute brain ischemia between 18 and 60 years. CHIP prevalence was compared with age-matched healthy controls from the Nijmegen Biomedical Study (n=1604) and the UK Biobank (n=101 678). Patients with suspicion of high-risk CHIP or myeloid neoplasm were invited for further hematologic evaluation.

Results

We included 248 consecutive patients (39% women) of whom 176 (71%) had cryptogenic stroke etiology. Fifty-one (21%) patients had CHIP, 3-fold more than in the general population (7.7% versus 2.6% for the Nijmegen Biomedical Study and 11.9% versus 4.1% for UK Biobank; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsStrokeHumansFemaleMaleClonal HematopoiesisPrevalenceProspective StudiesCarotid Intima-Media ThicknessHematopoiesisMutation

Stichwörter der Autor:innen

clonal hematopoiesishumansischemic strokemyeloproliferative disordersstroke

Autor:innen und Institutionen

  • Department of Neurology and Neurophysiology (E.M., C.S., A.H.), Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Germany.
  • Center for Genomic Medicine (E.M., M.K.G., M.M.U., J.R., P.N.), Massachusetts General Hospital, Boston.
  • Department of Neurology (E.M., M.K.G., J.R.), Massachusetts General Hospital, Boston.
  • Program in Medical and Population Genetics (E.M., M.K.G., M.M.U., J.R., P.N.), Broad Institute of MIT and Harvard, Cambridge, MA.
  • Department of Medicine I (H.B.), Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Germany.
  • Institute for Stroke and Dementia Research, University Hospital, Ludwig Maximilian University of Munich, Germany (M.K.G.).

ORCID-Profile: Ernst Mayerhofer, Christoph Strecker, Heiko Becker, Marios K Georgakis, Md Mesbah Uddin, Michael M Hoffmann, Jonathan Rosand, Pradeep Natarajan, Christopher D Anderson, Andreas Harloff, Gregor Hoermann

Förderung

  • American Heart Association-American Stroke Association
  • NHLBI NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Mayerhofer, E., Strecker, C., Becker, H., Georgakis, M. K., Uddin, M. M., Hoffmann, M. M., Nadarajah, N., Meggendorfer, M., Haferlach, T., Rosand, J., Natarajan, P., Anderson, C. D., Harloff, A., & Hoermann, G. (2023). Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke. Stroke. https://doi.org/10.1161/strokeaha.122.041416

Vancouver

Mayerhofer E, Strecker C, Becker H, Georgakis MK, Uddin MM, Hoffmann MM, et al. Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke. Stroke. 2023. doi:10.1161/strokeaha.122.041416

BibTeX
@article{Mayerhofer2023,
  author = {Mayerhofer, Ernst and Strecker, Christoph and Becker, Heiko and Georgakis, Marios K and Uddin, Md Mesbah and Hoffmann, Michael M and Nadarajah, Niroshan and Meggendorfer, Manja and Haferlach, Torsten and Rosand, Jonathan and Natarajan, Pradeep and Anderson, Christopher D and Harloff, Andreas and Hoermann, Gregor},
  title = {Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke},
  journal = {Stroke},
  year = {2023},
  doi = {10.1161/strokeaha.122.041416}
}
Kostenlos starten →